Seddik Hammad

Prof. Seddik Hammad

Molecular Hepatology Section, Department of Medicine II, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany
orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 August 2013 in Archives of Toxicology
Verified
Journal Article
Open access
PDF file
PGPatricio Godoy
Patricio Godoy
NHNicola J. Hewitt
Nicola J. Hewitt
UAUte Albrecht
Ute Albrecht
MAMelvin E. Andersen
Melvin E. Andersen
NANariman Ansari
Nariman Ansari
Jan G HengstlerJan G Hengstler
Jan G Hengstler
This review encompasses the most important advances in liver functions and hepatotoxicity and analyzes which mechanisms can be studied in vitro. In a complex architecture of nested, zonated lobules, the liver consists of approximately 80 % hepatocytes and 20 % non-parenchymal cells, the latter being involved in a secondary phase that may dramatically aggravate the initial damage. Hepatotoxicity, as well as hepatic metabolism, is controlled by a set of nuclear receptors (including PXR, CAR, HNF-4α, FXR, LXR, SHP, VDR and PPAR) and signaling pathways. When isolating liver cells, some pathways are activated, e.g., the RAS/MEK/ERK pathway, whereas others are silenced (e.g. HNF-4α), resulting in up- and downregulation of hundreds of genes. An understanding of these changes is crucial for a correct interpretation of in vitro data. The possibilities and limitations of the most useful liver in vitro systems are summarized, including three-dimensional culture techniques, co-cultures with non-parenchymal cells, hepatospheres, precision cut liver slices and the isolated perfused liver. Also discussed is how closely hepatoma, stem cell and iPS cell-derived hepatocyte-like-cells resemble real hepatocytes. Finally, a summary is given of the state of the art of liver in vitro and mathematical modeling systems that are currently used in the pharmaceutical industry with an emphasis on drug metabolism, prediction of clearance, drug interaction, transporter studies and hepatotoxicity. One key message is that despite our enthusiasm for in vitro systems, we must never lose sight of the in vivo situation. Although hepatocytes have been isolated for decades, the hunt for relevant alternative systems has only just begun.

30 April 2012 in Clinical Cancer Research
Verified
Journal Article
Open access
PDF file
Marcus SchmidtMarcus Schmidt
Marcus Schmidt
BHBirte Hellwig
Birte Hellwig
SHSeddik Hammad
Seddik Hammad
AOAmnah Othman
Amnah Othman
MLMiriam Lohr
Miriam Lohr
Jan G HengstlerJan G Hengstler
Jan G Hengstler
Purpose: Although the central role of the immune system for tumor prognosis is generally accepted, a single robust marker is not yet available.

1 June 2013 in Cancer Letters
Verified
Journal Article
Closed access
MLMiriam Lohr
Miriam Lohr
KEKarolina Edlund
Karolina Edlund
JBJohan Botling
Johan Botling
SHSeddik Hammad
Seddik Hammad
BHBirte Hellwig
Birte Hellwig
PMPatrick Micke
Patrick Micke

1 October 2015 in Journal of Hepatology
Verified
Journal Article
Open access
PGPatricio Godoy
Patricio Godoy
WSWolfgang Schmidt-Heck
Wolfgang Schmidt-Heck
KNKarthick Natarajan
Karthick Natarajan
BLBaltasar Lucendo-Villarin
Baltasar Lucendo-Villarin
Dagmara SzkolnickaDagmara Szkolnicka
Dagmara Szkolnicka
Jan G HengstlerJan G Hengstler
Jan G Hengstler
The differentiation of stem cells to hepatocyte-like cells (HLC) offers the perspective of unlimited supply of human hepatocytes. However, the degree of differentiation of HLC remains controversial. To obtain an unbiased characterization, we performed a transcriptomic study with HLC derived from human embryonic and induced stem cells (ESC, hiPSC) from three different laboratories. Genome-wide gene expression profiles of ESC and HLC were compared to freshly isolated and up to 14days cultivated primary human hepatocytes. Gene networks representing successful and failed hepatocyte differentiation, and the transcription factors involved in their regulation were identified. Gene regulatory network analysis demonstrated that HLC represent a mixed cell type with features of liver, intestine, fibroblast and stem cells. The "unwanted" intestinal features were associated with KLF5 and CDX2 transcriptional networks. Cluster analysis identified highly correlated groups of genes associated with mature liver functions (n=1057) and downregulated proliferation associated genes (n=1562) that approach levels of primary hepatocytes. However, three further clusters containing 447, 101, and 505 genes failed to reach levels of hepatocytes. Key TF of two of these clusters include SOX11, FOXQ1, and YBX3. The third unsuccessful cluster, controlled by HNF1, CAR, FXR, and PXR, strongly overlaps with genes repressed in cultivated hepatocytes compared to freshly isolated hepatocytes, suggesting that current in vitro conditions lack stimuli required to maintain gene expression in hepatocytes, which consequently also explains a corresponding deficiency of HLC. The present gene regulatory network approach identifies key transcription factors which require modulation to improve HLC differentiation.

19 April 2014 in Archives of Toxicology
Verified
Journal Article
Open access
PDF file
SHSeddik Hammad
Seddik Hammad
Stefan HöhmeStefan Höhme
Stefan Höhme
AFAdrian Friebel
Adrian Friebel
IRIris von Recklinghausen
Iris von Recklinghausen
AOAmnah Othman
Amnah Othman
Jan G HengstlerJan G Hengstler
Jan G Hengstler
Histological alterations often constitute a fingerprint of toxicity and diseases. The extent to which these alterations are cause or consequence of compromised organ function, and the underlying mechanisms involved is a matter of intensive research. In particular, liver disease is often associated with altered tissue microarchitecture, which in turn may compromise perfusion and functionality. Research in this field requires the development and orchestration of new techniques into standardized processing pipelines that can be used to reproducibly quantify tissue architecture. Major bottlenecks include the lack of robust staining, and adequate reconstruction and quantification techniques. To bridge this gap, we established protocols employing specific antibody combinations for immunostaining, confocal imaging, three-dimensional reconstruction of approximately 100-μm-thick tissue blocks and quantification of key architectural features. We describe a standard procedure termed ‘liver architectural staining’ for the simultaneous visualization of bile canaliculi, sinusoidal endothelial cells, glutamine synthetase (GS) for the identification of central veins, and DAPI as a nuclear marker. Additionally, we present a second standard procedure entitled ‘S-phase staining’, where S-phase-positive and S-phase-negative nuclei (stained with BrdU and DAPI, respectively), sinusoidal endothelial cells and GS are stained. The techniques include three-dimensional reconstruction of the sinusoidal and bile canalicular networks from the same tissue block, and robust capture of position, size and shape of individual hepatocytes, as well as entire lobules from the same tissue specimen. In addition to the protocols, we have also established image analysis software that allows relational and hierarchical quantifications of different liver substructures (e.g. cells and vascular branches) and events (e.g. cell proliferation and death). Typical results acquired for routinely quantified parameters in adult mice (C57Bl6/N) include the hepatocyte volume (5,128.3 ± 837.8 μm3) and the fraction of the hepatocyte surface in contact with the neighbouring hepatocytes (67.4 ± 6.7 %), sinusoids (22.1 ± 4.8 %) and bile canaliculi (9.9 ± 3.8 %). Parameters of the sinusoidal network that we also routinely quantify include the radius of the sinusoids (4.8 ± 2.25 μm), the branching angle (32.5 ± 11.2°), the length of intersection branches (23.93 ± 5.9 μm), the number of intersection nodes per mm3 (120.3 × 103 ± 42.1 × 103), the average length of sinusoidal vessel per mm3 (5.4 × 103 ± 1.4 × 103mm) and the percentage of vessel volume in relation to the whole liver volume (15.3 ± 3.9) (mean ± standard deviation). Moreover, the provided parameters of the bile canalicular network are: length of the first-order branches (7.5 ± 0.6 μm), length of the second-order branches (10.9 ± 1.8 μm), length of the dead-end branches (5.9 ± 0.7 μm), the number of intersection nodes per mm3 (819.1 × 103 ± 180.7 × 103), the number of dead-end branches per mm3 (409.9 × 103 ± 95.6 × 103), the length of the bile canalicular network per mm3 (9.4 × 103 ± 0.7 × 103 mm) and the percentage of the bile canalicular volume with respect to the total liver volume (3.4 ± 0.005). A particular strength of our technique is that quantitative parameters of hepatocytes and bile canalicular as well as sinusoidal networks can be extracted from the same tissue block. Reconstructions and quantifications performed as described in the current protocols can be used for quantitative mathematical modelling of the underlying mechanisms. Furthermore, protocols are presented for both human and pig livers. The technique is also applicable for both vibratome blocks and conventional paraffin slices.

1 July 2015 in Journal of Biotechnology
Verified
Journal Article
Closed access
JKJin-Young Kim
Jin-Young Kim
DFDavid A. Fluri
David A. Fluri
RMRosemarie Marchan
Rosemarie Marchan
KBKurt Boonen
Kurt Boonen
SMSoumyaranjan Mohanty
Soumyaranjan Mohanty
OFOlivier Frey
Olivier Frey